Terms: = Colorectal cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
500 results:
1. Local Anesthetic Bupivacaine Inhibits Melanoma Proliferation and Metastasis by Targeting PAPSS2.
Guan E; Zhang J; Zhou J; Liu Y; Xu N
Discov Med; 2024 Jul; 36(186):1499-1512. PubMed ID: 39054720
[TBL] [Abstract] [Full Text] [Related]
2. Shen-Qi-Ling-Bi Decoction Inhibits colorectal cancer Cell Growth by Inducing Ferroptosis Through Inactivation of PI3K/AKT Signaling Pathway.
Liu L; Ye G; Huang W; He Y; Xie D
DNA Cell Biol; 2024 Jul; 43(7):315-324. PubMed ID: 38884168
[TBL] [Abstract] [Full Text] [Related]
3. ATF4 inhibits tumor development and mediates p-GCN2/ASNS upregulation in colon cancer.
Chen J; Huang X; Zhang S; Zhu X
Sci Rep; 2024 Jun; 14(1):13042. PubMed ID: 38844625
[TBL] [Abstract] [Full Text] [Related]
4. A Novel Photosensitizer Based 450-nm Blue Laser-Mediated Photodynamic Therapy Induces Apoptosis in colorectal cancer -
Mei Y; Gu L; Chen Y; Zhang P; Cheng Y; Yuan R; Li X; Wang X; Guo P; He D; Zeng J
Front Biosci (Landmark Ed); 2024 May; 29(5):199. PubMed ID: 38812322
[TBL] [Abstract] [Full Text] [Related]
5. Brexpiprazole Prevents the Malignant Progression of Human colorectal cancer Cells and Increases Its Sensitivity to EGFR Inhibition.
Long X; Liu X; Xia W; Liu L; Chen W
Front Biosci (Landmark Ed); 2024 May; 29(5):174. PubMed ID: 38812296
[TBL] [Abstract] [Full Text] [Related]
6. ctDNA as a predictor of outcome after curative resection for locally advanced rectal cancer: systematic review and meta-analysis.
Nassar A; Aly NE; Jin Z; Aly EH
Colorectal Dis; 2024 Jul; 26(7):1346-1358. PubMed ID: 38802990
[TBL] [Abstract] [Full Text] [Related]
7. Liensinine sensitizes colorectal cancer cells to oxaliplatin by targeting HIF-1α to inhibit autophagy.
Feng Z; Zhang S; Han Q; Chu T; Wang H; Yu L; Zhang W; Liu J; Liang W; Xue J; Wu X; Zhang C; Wang Y
Phytomedicine; 2024 Jul; 129():155647. PubMed ID: 38703660
[TBL] [Abstract] [Full Text] [Related]
8. OSW-1 triggers necroptosis in colorectal cancer cells through the RIPK1/RIPK3/MLKL signaling pathway facilitated by the RIPK1-p62/SQSTM1 complex.
Wang N; Li CY; Yao TF; Kang XD; Guo HS
World J Gastroenterol; 2024 Apr; 30(15):2155-2174. PubMed ID: 38681991
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1.
Zhang J; Wang Y; Hou S; Chi X; Ding D; Xue M; Zhang M; Wang J; Shuai J; Sun H; Gao Q; Kang C
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666541
[TBL] [Abstract] [Full Text] [Related]
10. Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment.
Ottaiano A; Santorsola M; Ianniello M; Ceccarelli A; Casillo M; Sabbatino F; Petrillo N; Cascella M; Caraglia F; Picone C; Perri F; Sirica R; Zappavigna S; Nasti G; Savarese G; Caraglia M
J Transl Med; 2024 Apr; 22(1):379. PubMed ID: 38650006
[TBL] [Abstract] [Full Text] [Related]
11. Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence?
Stucchi E; Bartolini M; Airoldi M; Fazio R; Daprà V; Mondello G; Prete MG; Puccini A; Santoro A
Expert Opin Pharmacother; 2024 Mar; 25(4):371-382. PubMed ID: 38568032
[TBL] [Abstract] [Full Text] [Related]
12. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
13. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
[TBL] [Abstract] [Full Text] [Related]
14. A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic colorectal cancer: WJOG 11018G.
Matsumoto T; Yamamoto Y; Kotaka M; Masuishi T; Tsuji Y; Shoji H; Hirata K; Tsuduki T; Makiyama A; Izawa N; Takahashi N; Tsuda M; Yasui H; Ohta T; Kito Y; Otsu S; Hironaka S; Yamazaki K; Boku N; Hyodo I; Yoshimura K; Muro K
Target Oncol; 2024 Mar; 19(2):181-190. PubMed ID: 38427280
[TBL] [Abstract] [Full Text] [Related]
15. HSK3486 Inhibits colorectal cancer Growth by Promoting Oxidative Stress and ATPase Inhibitory Factor 1 Activation.
Nan K; Zhong Z; Yue Y; Zhou W; Sun X; Shen Y; Qu M; Chen Z; Gu J; Sun C; Sun X; Lu L; Zhang J; Miao C; Sun M
Dig Dis Sci; 2024 Apr; 69(4):1214-1227. PubMed ID: 38376789
[TBL] [Abstract] [Full Text] [Related]
16. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
[TBL] [Abstract] [Full Text] [Related]
17. Effect of Cichoric Acid on colorectal cancer: Impact on Migration, Epithelial-Mesenchymal Transition, and Proliferation
Ma S; Huang Z; Chen Q; Yin X
Discov Med; 2024 Jan; 36(180):190-198. PubMed ID: 38273759
[TBL] [Abstract] [Full Text] [Related]
18. Entero-toxigenic
Yang J; Wang X; Hu T; Huang H; Chen G; Jin B; Zeng G; Liu J
Cell Cycle; 2024 Jan; 23(1):70-82. PubMed ID: 38273425
[TBL] [Abstract] [Full Text] [Related]
19. The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Voissière A; Gomez-Roca C; Chabaud S; Rodriguez C; Nkodia A; Berthet J; Montane L; Bidaux AS; Treilleux I; Eberst L; Terret C; Korakis I; Garin G; Pérol D; Delord JP; Caux C; Dubois B; Ménétrier-Caux C; Bendriss-Vermare N; Cassier PA
Sci Transl Med; 2024 Jan; 16(731):eadd1834. PubMed ID: 38266104
[TBL] [Abstract] [Full Text] [Related]
20. Astragaloside IV regulates circ_0001615 and miR-873-5p/LASP1 axis to suppress colorectal cancer cell progression.
Kong P; Tang X; Liu F; Tang X
Chem Biol Drug Des; 2024 Jan; 103(1):e14423. PubMed ID: 38230773
[TBL] [Abstract] [Full Text] [Related]
[Next]
